189 related articles for article (PubMed ID: 17322931)
1. Graft-versus-leukemia in chronic lymphocytic leukemia.
Ben-Bassat I; Raanani P; Gale RP
Bone Marrow Transplant; 2007 Apr; 39(8):441-6. PubMed ID: 17322931
[TBL] [Abstract][Full Text] [Related]
2. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-leukemia following bone marrow transplantation.
Butturini A; Bortin MM; Gale RP
Bone Marrow Transplant; 1987 Oct; 2(3):233-42. PubMed ID: 3332173
[TBL] [Abstract][Full Text] [Related]
4. Acute skin GVHD following syngeneic BMT for CLL.
Deane M; Singer C; Lawler M; McElwaine S; Gomez K; Prentice HG
Bone Marrow Transplant; 1998 Dec; 22(12):1207-9. PubMed ID: 9894725
[TBL] [Abstract][Full Text] [Related]
5. Graft-vs-leukemia following bone marrow transplantation: a model of immunotherapy in man.
Butturini A; Bortin MM; Seeger RC; Gale RP
Prog Clin Biol Res; 1987; 244():371-90. PubMed ID: 3310000
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.
Champlin R
Transplant Proc; 1991 Aug; 23(4):2123-7. PubMed ID: 1871828
[TBL] [Abstract][Full Text] [Related]
7. Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia.
deMagalhaes-Silverman M; Donnenberg A; Hammert L; Lister J; Myers D; Simpson J; Ball E
Bone Marrow Transplant; 1997 Jul; 20(2):175-7. PubMed ID: 9244424
[TBL] [Abstract][Full Text] [Related]
8. Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?
Hari P; Logan B; Drobyski WR
Biol Blood Marrow Transplant; 2004 Nov; 10(11):743-7. PubMed ID: 15505605
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
[TBL] [Abstract][Full Text] [Related]
10. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
[TBL] [Abstract][Full Text] [Related]
11. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for chronic lymphocytic leukemia.
Flinn IW; Vogelsang G
Semin Oncol; 1998 Feb; 25(1):60-4. PubMed ID: 9482527
[TBL] [Abstract][Full Text] [Related]
13. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.
Sprangers B; Van Wijmeersch B; Fevery S; Waer M; Billiau AD
Nat Clin Pract Oncol; 2007 Jul; 4(7):404-14. PubMed ID: 17597705
[TBL] [Abstract][Full Text] [Related]
14. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
15. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S
Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627
[TBL] [Abstract][Full Text] [Related]
16. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.
Reddy P; Maeda Y; Liu C; Krijanovski OI; Korngold R; Ferrara JL
Nat Med; 2005 Nov; 11(11):1244-9. PubMed ID: 16227991
[TBL] [Abstract][Full Text] [Related]
17. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.
Alyea EP
Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
[TBL] [Abstract][Full Text] [Related]
19. Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
Ritgen M; Böttcher S; Stilgenbauer S; Bunjes D; Schubert J; Cohen S; Humpe A; Hallek M; Kneba M; Schmitz N; Döhner H; Dreger P;
Leukemia; 2008 Jul; 22(7):1377-86. PubMed ID: 18418404
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion.
Porter D; Levine JE
Semin Hematol; 2006 Jan; 43(1):53-61. PubMed ID: 16412789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
